Prevalence study of Pseudomonas aeruginosa in Teaching Tikrit Hospital from different sources.
Main Article Content
Abstract
In the current study,it was isolated 117 samples from different sources ,the isolates were identification using bacteriological and biochemical tests,(bacteria swabs uptaked from wound, otitis media ,stool and urine and), ,out of 117 samples. only 18 specimens was positive for P.aeruginosa (14%) in the otitis media,(14%) in the stool,(3%) in the wound and (0%) in the urine.all bacterial isolates identified through the using of bacterial and biochemical test ,.P.aeruginosa isolates showed highy resistance to most used antibiotics especially Ceftriaxon (CRO), Erythromycin (E), Cefixime (CFM)100% followed by Cefepime (FEP), Carbenicillin (PY)44%, Tobramycin (TOB)22% and Piperacillin (PRL)16.66% but Norfloxacin (NOR) show the attractive activities against all P.aeruginosa isolates ,the resistance was 0%.
Conclusion: P.aeruginosa isolated in low prevalence in the Teaching Tikrit Hospital only in 15,38% ,all bacterial isolates was multi drug resistance (MDR) ,and resist to most used antibiotics expect Norfloxacin (NOR).
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1- Pollack, M. (2000). Pseudomonas aeruginosa. In principle and practice of infection Diseases. Spp.2310-2335.Edited by G. L.Mandell; J. E. Bennett and R, Dolin. Philadelphia: Churchill Livingstone. -Pollack, M. (2000). Pseudomonas aeruginosa. In principle and practice of infection Diseases. Spp. 2310-2335. Edited by G. L. Mandell; J. E. Bennett and R, Dolin. Philadelphia: Churchill Livingstone.
2- Stover, C. K.; Pham, X. Q.; Erwin ,A. L.; Mizogushi, S. D.; Warrener ,P.; Hickey ,M. J.; Brinkman ,F.S. L.; Hufnagle, W. O.; Kowalik, D. J.; Lagrou, M.; Garber ,R.L.; Goltry, L.; Tolentino, E.; Westbrock - Wadman ,S.; Yuan, Y.; L.L.; Brody ,S. Coulter,N.; Folger ,K. R.; Kas, A.; Larbig, K.; Lim , R.; Smith, K.; Spencer ,D.; Wong ,G. K.S.; Wu, Z.; Paulsenk ,I. T.; Reizer, J.; Saier, M. H.; Hancock, R. E. W.; Lory, S. and Olson, M. V. (2000). Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature Vol. 406.
3- Akanji, B.O.J.O.; Ajele, A.; Onasanya .and Oyelakin, O. (2011). "Genetic Fingerprinting of Pseudomonas aeruginosa Involved in Nosocomial Infection as Revealed by RAPD-PCR Markers" Biotech. Vol. 10, no. 1, pp.70-77.
4- Anderlini, P.; Przepiorka, D.; Champlin, R. and Korbling, M. (1996) .Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood.88:2819-2825.
5-Brooks,G.F. ;Butel,J.S. and Morse,S.A. (2001). Medical Microbiology. 22nd ed . p. 229–231. Medical East ed ; Appleton Large.
6- Collee, J.G.; Fraser, A.G.; Marmion, B.P. and Simmons,A. (1996). Mackie and Mecartney . Practical Medical Microbiology. 14th ed .,Churchill Living stone, USA. p.413 – 424.
7- Bauer, A.W.; Kirby, W.M.M.; Sherries, J.C. and Turk, M. (1966). Antibiotic Susceptibility Testing by a Standardized Single Disc Method. Am. J. Clin. Pathol., 45 : 493 – 496 .
8- Morrison, A.J. and Wenzel, R.P. (1984). Epidemiology of Infections Due to Pseudomonas aeruginosa .Rev. Infect. Dis. 6 (3) : 5627-5642 .
9- Gorbach, S.L.; Bartlett, J.G.; and Blacklow, N.R. (1998). Infectious Diseases . 2nd ed . Part VII . W.B. Saunders Company ,A Division of Harcourt Brace Company. p. 1824.
10- Baron, E.T. and Finegold, S. (1990) . Diagnostic Microbiology ,8th ed. Bailey &Scott’s the C.V. Mosby, Co., USA.
11- Macfaddin, J.F. (2000). Biochemical tests for Identification of Medical Bacteria 3rd ed .p. 689 – 691 .The Williams & Wilkins Co., USA.
12- Mortimer, P. S.; Heinz, S.; Hans, G. ;Truper, A.B. and Hans, G. S. (1981). The prokaryotes a handbook on habitats, isolation and identification of bacteria. Springer- Verlag. Berlin Heidelberg New York, vol. II.
13- Herfindal, E.T. and Gourley, D.R. (2000) . Textbook of Therapeutics ,Drug and Disease Management 7th ed . Lippincott Williams & Wilkins, A Wolters Kluwer Co., USA.p.1049-1054.
14- Latif, A.; M.K. Winson.; M. Foglino.; B.W. Bycroft.; G.S. Stewart.; A.Lazdunski.; P. Williams. (1995). Multiple homologues of LuxR and LuxI control expression of virulence determinants and secondary metabolites through quorum sensing in Pseudomonas aeruginosa PAO1. Mol Microbiol, 17:333-343.
15- Hayder, N.; Bouhlel, I.; Skandrani, I.(2008). In vitro antioxidant and antigenotoxic potentials of myricetin- 3- ogalactosideand myricetin -3-o-rhamnoside from Myrtus
communis: Modulation of expression of genes involved incell defence system using cDNA microarray. Toxicol In Vitro .22(3): 567-581.
16- Al-Salihi, S.SH.; Hameed, B.H. and Hameed, B.H. (2014) Antibiosis resistant of Pseudomonas aeruginosa isolated from different clinical specimens. kirkuk. J.9:16-28.
17- Ogunseilan, O.(2005). "Microbial Diversity, form and function in prokaryotes". Blackwell. USA.
18- Bhatt, C.P.; Sherstha, B.; Khadka, S.; Swar, S.; Shah, B. and Punk, K.(2012) Etiology of urinary tract infection and drug resistance cases of uropathogenes .Kath med.J.1:114-118.
19- Jaafar, M.Z.; Dhahi, M.A.R.; Abd, A.H. and Jaafar, S.M. (2014) Molecular identification and antibiotics resistance genes profile of Pseudomonas aeruginosa isolated from Iraqi patients . Afr. J. Microbiol. Res.8:2184-2191.
20- Jouda, M.M. (2013) The antibacterial effect of some medical plant extracts and their synergestic effect with antibiotic and non-antibiotic drug. M.S.C. Thesis in microbiology. college of science. Gaza univ.
21- Flayyih, M.T., Yousif, H., Subhi, I.M. (2013) Antimicrobial effects of black tea (Camellia sinensis) on Pseudomonas aeruginosa isolated from eye infection.Iraqi.J.255-265.
22- Naher, H.S. and Hamza, L.F.(2009) Antibiotics resistance of Pseudomonas aeruginosa isolated from clinical cases in hilla city .Med babyl.J.6:243-253.
23- Araj GF, Avedissian AZ, Ayyash NS, Bey HA, El Asmar RG, Hammoud RZ, Itani LY, Malak MR, Sabai SA.(2012). A reflection onbacterial resistance to antimicrobial agents at a major tertiarycare center in Lebanon over a decade. J Med Liban .60 (3) :125-135.
24- Radi, R.O. and Rahman, F.H. (2010) Study the effects of ethedium bromide, SDS and elevated temperature on stability of multiple antibiotic resistances plasmids of Pseudomonas aeruginosa .Iraqi.j.Biotech.9:797-811.
25- Finlayson ,E.A and Brown, P.D .(2011) Comparison of Antibiotic Resistance and Virulence Factors in Pigmented and Non-pigmented Pseudomonas aeruginosa. West Indian Med J.60:24-31.
26- Eftekhar, F.; Hosseinkhan, N.; Asgharzadeh, A.and Tabatabaii, A.(2009) .Genetic profiling of Pseudomonas aeruginosa isolates fromIranian patients with cystic fibrosis using RAPD-PCR and PFGE. Iranian J Basic Med Sci .12: 126–132.
27- Henwood, C.J.; Livermore, D.M.; James, D. and Warner, M. (2001). Antimicrobial Chemotherapy Disc Susceptibility Test. J-Antimicrob-chemother. 47 (6) :789 -99 .